You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NASH

Showing 26 - 50 of 1,247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NASH - Nonalcoholic Steatohepatitis Trial in Boston (Estradiol patch, Placebo)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Estradiol patch
  • Placebo
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 8, 2022

Early Liver Disease Breath Detection

Not yet recruiting
  • Liver Fibrosis
  • +2 more
  • EVOCs emulsion
  • Norwich, Norfolk, United Kingdom
    One Norwich Practises
Jun 28, 2023

Liver Diseases Trial (Liver Fine-Needle Aspiration)

Not yet recruiting
  • Liver Diseases
  • Liver Fine-Needle Aspiration
  • (no location specified)
Nov 29, 2023

Steatohepatitis, Nonalcoholic Trial in Düsseldorf, Wuppertal (Formula diet)

Recruiting
  • Steatohepatitis, Nonalcoholic
  • Formula diet
  • Düsseldorf, Germany
  • +1 more
Jul 19, 2022

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023

NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

Recruiting
  • NON-ALCOHOLIC STEATOHEPATITIS
  • Rialto, California
  • +5 more
Sep 19, 2023

Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis Trial in Tustin, Jerusalem, Tel Aviv (ORMD-0801 (Insulin) capsule 8 mg BD,

Completed
  • Diabetes Mellitus, Type 2
  • NASH - Nonalcoholic Steatohepatitis
  • ORMD-0801 (Insulin) capsule 8 mg BD
  • Placebo
  • Tustin, California
  • +2 more
Sep 13, 2022

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2, Hyperlipidemias Trial in Frankfurt, Mainz (Nutritional Intervention)

Active, not recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • +2 more
  • Nutritional Intervention
  • Frankfurt, Germany
  • +1 more
Mar 28, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Miricorilant 150 mg, Miricorilant 100 mg)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miricorilant 150 mg
  • +2 more
  • Chandler, Arizona
  • +9 more
Oct 27, 2022

Patient Demographics, Comorbidities, and Medications on Severity

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • NAFLD/NASH
  • Dallas, Texas
    Methodist Dallas Medical Center
Apr 27, 2022

Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Argentina, Germany, United States (LYS006, LYS006 +

Terminated
Has Results
  • Non-alcoholic Fatty Liver Disease
  • Nonalcoholic Steatohepatitis
  • Coronado, California
  • +9 more
Jan 10, 2023

Nonalcoholic Steatohepatitis Trial in Israel (5 mg/kg CM-101, Placebo)

Completed
  • Nonalcoholic Steatohepatitis
  • 5 mg/kg CM-101
  • Placebo
  • Be'er Sheva, Israel
  • +8 more
Apr 11, 2023

Platelet Inflammatory Response in NAFL and NASH

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • NAFLD
  • High fat meal in a subset of patients with NAFL or NASH
  • Rome, Italy
  • +1 more
Dec 27, 2021

NASH - Nonalcoholic Steatohepatitis Trial in United States (Liver Multi Scan)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Liver Multi Scan
  • New York, New York
  • +3 more
Apr 22, 2022

Splanchnic and Systemic VLDL-TG and FFA Balance

Completed
  • NAFLD
  • NASH - Nonalcoholic Steatohepatitis
    • Skejby, Aarhus N, Denmark
      Arhus University Hospital Department of Endocrinology and Intern
    May 23, 2022

    Nonalcoholic Steatohepatitis (NASH) Trial in United States (BOS-580, Placebo)

    Active, not recruiting
    • Nonalcoholic Steatohepatitis (NASH)
    • Birmingham, Alabama
    • +11 more
    Dec 4, 2022

    NASH - Nonalcoholic Steatohepatitis Trial in Chandler (BIO89-100)

    Completed
    • NASH - Nonalcoholic Steatohepatitis
    • Chandler, Arizona
      89bio Clinical Study Site
    Feb 28, 2022

    NASH Trial in Puerto Rico, United States (BIO89-100, Placebo)

    Completed
    • NASH
    • Madison, Alabama
    • +25 more
    Nov 28, 2022

    Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) Trial in Charlottesville (AZ compound, Placebo)

    Terminated
    Has Results
    • Non-alcoholic Fatty Liver Disease (NAFLD)
    • Non-alcoholic Steatohepatitis (NASH)
    • AZ compound
    • Placebo
    • Charlottesville, Virginia
      Yogesh Yadav
    Mar 10, 2022

    Steatohepatitis Trial in Puerto Rico, United States (AZD7503)

    Recruiting
    • Steatohepatitis
    • Chandler, Arizona
    • +10 more
    May 16, 2023

    NASH - Nonalcoholic Steatohepatitis, NAS, Overweight or Obesity Trial in Minneapolis (Vertical Sleeve Gastrectomy (VSG))

    Recruiting
    • NASH - Nonalcoholic Steatohepatitis
    • +4 more
    • Vertical Sleeve Gastrectomy (VSG)
    • Minneapolis, Minnesota
      University of Minnesota
    Feb 9, 2022

    Nonalcoholic Steatohepatitis Trial (Saroglitazar Magnesium 4 mg, Placebo)

    Not yet recruiting
    • Nonalcoholic Steatohepatitis
    • Saroglitazar Magnesium 4 mg
    • Placebo
    • (no location specified)
    Apr 23, 2022

    Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases Trial in Curitiba (NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER

    Active, not recruiting
    • Steatohepatitis, Nonalcoholic
    • +3 more
    • NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD).
    • Curitiba, Parana, Brazil
      Hospital de Clínicas da Universidade Federal do Paraná
    Jul 17, 2023

    cT1 for NASH (CATE-NASH)

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • LiverMultiscan
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 30, 2021

    Bariatric Surgery on NASH

    Active, not recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Obesity
      • Hellerup, Denmark
        Center for Clinical Metabolic Research
      Nov 2, 2022